Acrivon Therapeutics (NASDAQ:ACRV – Free Report) had its price objective decreased by LADENBURG THALM/SH SH from $18.00 to $14.00 in a research note published on Friday morning, Benzinga reports. LADENBURG THALM/SH SH currently has a buy rating on the stock. A number of other equities research analysts have also recently commented on ACRV. HC Wainwright […]
U.S. stocks traded higher this morning, with the Dow Jones index gaining over 50 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.20% to 38,972.32 while the NASDAQ rose 0.40% to 16,319.23. The S&P 500 also rose, gaining, 0.32% to 5,219.29.
Acrivon Therapeutics (ACRV) Announces $130 Million Private Placement Financing streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
U.S. stocks traded lower midway through trading, with the Dow Jones index falling around 150 points on Tuesday. The Dow traded down 0.39% to 38,742.12 while the NASDAQ fell 0.16% to 16,227.77. The S&P 500 also fell, dropping, 0.29% to 5,187.10.